Transcriptomic Signatures of Auger Electron Radioimmunotherapy Using Nuclear Targeting 111In-Trastuzumab for Potential Combination Therapies-Reference-Cited by-同舟云学术

Transcriptomic Signatures of Auger Electron Radioimmunotherapy Using Nuclear Targeting 111In-Trastuzumab for Potential Combination Therapies

Published:2015-10 Issue:8 Volume:30 Page:349-358
ISSN:1084-9785
Container-title:Cancer Biotherapy and Radiopharmaceuticals
language:en
Short-container-title:Cancer Biotherapy and Radiopharmaceuticals

Author:

Li Huizi Keiko¹²³,Morokoshi Yukie¹,Daino Kazuhiro⁴,Furukawa Takako¹,Kamada Tadashi²³,Saga Tsuneo¹,Hasegawa Sumitaka¹

Affiliation:

1. Molecular Imaging Center, National Institute of Radiological Sciences, Chiba, Japan.

2. Graduate School of Medical and Pharmaceutical Sciences, Chiba University, Chiba, Japan.

3. Research Center for Charged Particle Therapy, National Institute of Radiological Sciences, Chiba, Japan.

4. Research Center for Radiation Protection, National Institute of Radiological Sciences, Chiba, Japan.

Publisher

Mary Ann Liebert Inc

Subject

Cancer Research,Pharmacology,Radiology, Nuclear Medicine and imaging,Oncology,General Medicine,Cancer Research,Pharmacology,Radiology, Nuclear Medicine and imaging,Oncology,General Medicine

Link

http://www.liebertpub.com/doi/pdf/10.1089/cbr.2015.1882

Reference31 articles.

1. Dosimetry of Auger-electron-emitting radionuclides: Report No. 3 of AAPM Nuclear Medicine Task Group No. 6

2. Targeting the Nucleus: An Overview of Auger-Electron Radionuclide Therapy

3. Update:Peptide Motifs for Insertion of Radiolabeled Biomolecules into Cells and Routing to the Nucleus for Cancer Imaging or Radiotherapeutic Applications

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Estimation of biological effect of Cu-64 radiopharmaceuticals with Geant4-DNA simulation;Scientific Reports;2022-05-27

2. Favorable tumor uptake and nuclear transport of Auger electrons by nuclear targeting with 111In-trastuzumab in an intraperitoneal tumor mouse model;Nuclear Medicine Communications;2022-05-04

3. Assessment of cell cytotoxicity and comet assay on HER2/neu positive cell line due to 111In Auger electrons as DNA-targeting radioimmunoconjugate;Current Radiopharmaceuticals;2021-06-25

4. HER2-directed antibodies, affibodies and nanobodies as drug-delivery vehicles in breast cancer with a specific focus on radioimmunotherapy and radioimmunoimaging;European Journal of Nuclear Medicine and Molecular Imaging;2020-11-12

5. Advancements in the use of Auger electrons in science and medicine during the period 2015–2019;International Journal of Radiation Biology;2020-10-23